A Case Report on Scleroderma: A Diagnostic Dilema

Male, Ch. K. V. L. S. N. Anjana and Varikallu, Hari Chandana and Swapna, Tirumalasetty Sai and Dileep, N. and Prasad, S. Hemanth Durga and Nalla, Sarath (2021) A Case Report on Scleroderma: A Diagnostic Dilema. Journal of Pharmaceutical Research International, 33 (40A). pp. 251-255. ISSN 2456-9119

[thumbnail of 3038-Article Text-4761-1-10-20221006.pdf] Text
3038-Article Text-4761-1-10-20221006.pdf - Published Version

Download (169kB)

Abstract

Scleroderma is a rare heterogenous group of autoimmune fibrosing disorder that mainly exists in two forms; localized scleroderma (LS) and systemic sclerosis (SSc). It involves thickening of the skin at fingers region extending from proximal to metacarpophalangeal joints. The diagnostic criteria of scleroderma include past history of patient, symptoms of patient, serology, and skin biopsy. The morbidity and mortality are much worse for SSc with the patients are at risk for life threatening lung, heart and other visceral organ fibrosis and vasculopathy. There is no drug that can cure or stop scleroderma over fibrosis, but certain drugs regulate the symptoms associated with it and boost the patient's quality of life, particularly steroidal creams that help alleviate swelling, joint pain, loosen tight skin; blood pressure drugs that dilate blood vessels; immunosuppressive agents. If the disease is severe amputation is necessary.

Item Type: Article
Subjects: Journal Eprints > Medical Science
Depositing User: Managing Editor
Date Deposited: 13 Mar 2023 07:08
Last Modified: 04 Jun 2024 10:51
URI: http://repository.journal4submission.com/id/eprint/1384

Actions (login required)

View Item
View Item